HAART and liver: is it safe?
Introduction: Liver disease caused by hepatitis C virus (HCV) is a major cause of morbidity in HIV patients. This study investigates the possibility that chronic HCV increases the risk of hepatotoxicity after highly active antiretroviral therapy (HAART) initiation. Methodology: The data from 30 coi...
Saved in:
| Main Authors: | Vicente Sperb Antonello, Dimas Alexandre Kliemann, Breno Rigel Santos, Cristiane Valle Tovo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Journal of Infection in Developing Countries
2014-11-01
|
| Series: | Journal of Infection in Developing Countries |
| Subjects: | |
| Online Access: | https://jidc.org/index.php/journal/article/view/5012 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiretroviral therapy does not affect response to chronic hepatitis C therapy in HIV-coinfected patients
by: Luciana Brosina de Leon, et al.
Published: (2016-08-01) -
Nutritional status of HIV-positive individuals on free HAART treatment in a developing nation
by: Samuel Nnamdi Obi, et al.
Published: (2010-08-01) -
Evaluation of Fundoscopic Findings in HIV Positive Patients in Relation to HAART and CD4 Count
by: Ajit Kamalakar Joshi, et al.
Published: (2018-10-01) -
Predictors associated with time to default for HIV/AIDS patients under HAART at Debre Tabor Referral Hospital: a Cox regression model
by: Koyachew Bitew Abebe
Published: (2025-01-01) -
Prevalence of depression and associated factors among HIV/AIDS Patients on HAART in Okugu Refugee Camp, Gambella, Ethiopia
by: Adane Asefa, et al.
Published: (2025-05-01)